Molecular Mechanisms of Hepatic Steatosis and Insulin Resistance in the AGPAT2-Deficient Mouse Model of Congenital Generalized Lipodystrophy

Cell Metabolism

Volumn 9, Issue 2, 2009, Pages 165-176

  Cortés, Víctor A ^a   Curtis, David E ^a   Sukumaran, Suja ^a   Shao, Xinli ^a   Parameswara, Vinay ^a   Rashid, Shirya ^a   Smith, Amy R ^a   Ren, Jimin ^b   Esser, Victoria ^a   Hammer, Robert E ^a   Agarwal, Anil K ^a   Horton, Jay D ^a   Garg, Abhimanyu ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

HUMDISEASE

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 2; ACYLGLYCEROL PALMITOYLTRANSFERASE; ACYLGLYCEROL PALMITOYLTRANSFERASE 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONGENITAL GENERALIZED LIPODYSTROPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE SEVERITY; ENERGY EXPENDITURE; ENERGY METABOLISM; FAT INTAKE; FATTY ACID SYNTHESIS; FATTY LIVER; FEMALE; GENE EXPRESSION; INSULIN RESISTANCE; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEROL SYNTHESIS; WHITE ADIPOSE TISSUE;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ADIPOSE TISSUE; ANIMALS; ENERGY METABOLISM; FATTY LIVER; INSULIN RESISTANCE; LIPODYSTROPHY, CONGENITAL GENERALIZED; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; TRIGLYCERIDES;

MUS;

EID: 58749091644     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2009.01.002     Document Type: Article

References (62)

1. Agarwal A.K., and Garg A. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol. Metab. 14 (2003) 214-221
2. Agarwal A.K., and Garg A. Genetic disorders of adipose tissue development, differentiation, and death. Annu. Rev. Genomics Hum. Genet. 7 (2006) 175-199
3. Agarwal A.K., Arioglu E., de Almeida S., Akkoc N., Taylor S.I., Bowcock A.M., Barnes R.I., and Garg A. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31 (2002) 21-23
4. Agarwal A.K., Simha V., Oral E.A., Moran S.A., Gorden P., O'Rahilly S., Zaidi Z., Gurakan F., Arslanian S.A., Klar A., et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 88 (2003) 4840-4847
5. Agarwal A.K., Barnes R.I., and Garg A. Functional characterization of human 1-acylglycerol-3-phosphate acyltransferase isoform 8: cloning, tissue distribution, gene structure and enzymatic activity. Arch. Biochem. Biophys. 449 (2006) 64-76
6. Agarwal A.K., Sukumaran S., Bartz R., Barnes R.I., and Garg A. Functional characterization of human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 9: cloning, tissue distribution, gene structure, and enzymatic activity. J. Endocrinol. 193 (2007) 445-457
7. Beigneux A.P., Vergnes L., Qiao X., Quatela S., Davis R., Watkins S.M., Coleman R.A., Walzem R.L., Philips M., Reue K., and Young S.G. Agpat6-a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium. J. Lipid Res. 47 (2006) 734-744
8. Brindley D.N. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer. J. Cell. Biochem. 92 (2004) 900-912
9. Brindley D.N., and Waggoner D.W. Mammalian lipid phosphate phosphohydrolases. J. Biol. Chem. 273 (1998) 24281-24284
10. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114 (2004) 147-152
11. Buhman K.K., Smith S.J., Stone S.J., Repa J.J., Wong J.S., Knapp Jr. F.F., Burri B.J., Hamilton R.L., Abumrad N.A., and Farese Jr. R.V. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J. Biol. Chem. 277 (2002) 25474-25479
12. Cao J., Lockwood J., Burn P., and Shi Y. Cloning and functional characterization of a mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2. J. Biol. Chem. 278 (2003) 13860-13866
13. Cao J., Hawkins E., Brozinick J., Liu X., Zhang H., Burn P., and Shi Y. A predominant role of acyl-CoA:monoacylglycerol acyltransferase-2 in dietary fat absorption implicated by tissue distribution, subcellular localization, and up-regulation by high fat diet. J. Biol. Chem. 279 (2004) 18878-18886
14. Cao J., Li J.L., Li D., Tobin J.F., and Gimeno R.E. Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis. Proc. Natl. Acad. Sci. USA 103 (2006) 19695-19700
15. Carman G.M., and Han G.S. Roles of phosphatidate phosphatase enzymes in lipid metabolism. Trends Biochem. Sci. 31 (2006) 694-699
16. Carman G.M., and Han G.S. Phosphatidic acid phosphatase, a key enzyme in the regulation of lipid synthesis. J. Biol. Chem. (2008) 10.1074/jbc.R800059200 in press. Published online September 23, 2008
17. Chandalia M., Garg A., Vuitch F., and Nizzi F. Postmortem findings in congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 80 (1995) 3077-3081
18. Chen Y.Q., Kuo M.S., Li S., Bui H.H., Peake D.A., Sanders P.E., Thibodeaux S.J., Chu S., Qian Y.W., Zhao Y., et al. AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase. J. Biol. Chem. 283 (2008) 10048-10057
19. Donkor J., Sariahmetoglu M., Dewald J., Brindley D.N., and Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J. Biol. Chem. 282 (2007) 3450-3457
20. Duan S.Z., Ivashchenko C.Y., Whitesall S.E., D'Alecy L.G., Duquaine D.C., Brosius F.C., Gonzalez F.J., Vinson C., Pierre M.A., Milstone D.S., and Mortensen R.M. Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality. J. Clin. Invest. 117 (2007) 812-822
21. Engelking L.J., Kuriyama H., Hammer R.E., Horton J.D., Brown M.S., Goldstein J.L., and Liang G. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J. Clin. Invest. 113 (2004) 1168-1175
22. Fradkin J.E., Eastman R.C., Lesniak M.A., and Roth J. Specificity spillover at the hormone receptor-exploring its role in human disease. N. Engl. J. Med. 320 (1989) 640-645
23. Gale S.E., Frolov A., Han X., Bickel P.E., Cao L., Bowcock A., Schaffer J.E., and Ory D.S. A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation. J. Biol. Chem. 281 (2006) 11082-11089
24. Garg A. Acquired and genetic lipodystrophies. N. Engl. J. Med. 350 (2004) 1220-1234
25. Hammond L.E., Gallagher P.A., Wang S., Hiller S., Kluckman K.D., Posey-Marcos E.L., Maeda N., and Coleman R.A. Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol. Cell. Biol. 22 (2002) 8204-8214
26. Haque W., Garg A., and Agarwal A.K. Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy. Biochem. Biophys. Res. Commun. 327 (2005) 446-453
27. Hewitt K.N., Pratis K., Jones M.E., and Simpson E.R. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145 (2004) 1842-1848
28. Holland W.L., Brozinick J.T., Wang L.P., Hawkins E.D., Sargent K.M., Liu Y., Narra K., Hoehn K.L., Knotts T.A., Siesky A., et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5 (2007) 167-179
29. Horton J.D. Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 30 (2002) 1091-1095
30. Horton J.D., Shimano H., Hamilton R.L., Brown M.S., and Goldstein J.L. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. J. Clin. Invest. 103 (1999) 1067-1076
31. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., and Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92 (1993) 883-893
32. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., and Simpson E.R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. USA 97 (2000) 12735-12740
33. Joseph S.B., Laffitte B.A., Patel P.H., Watson M.A., Matsukuma K.E., Walczak R., Collins J.L., Osborne T.F., and Tontonoz P. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem. 277 (2002) 11019-11025
34. Leung D.W. The structure and functions of human lysophosphatidic acid acyltransferases. Front. Biosci. 6 (2001) d944-d953
35. Li D., Yu L., Wu H., Shan Y., Guo J., Dang Y., Wei Y., and Zhao S. Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family. J. Hum. Genet. 48 (2003) 438-442
36. Liang G., Yang J., Horton J.D., Hammer R.E., Goldstein J.L., and Brown M.S. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277 (2002) 9520-9528
37. Markham J.E., Li J., Cahoon E.B., and Jaworski J.G. Separation and identification of major plant sphingolipid classes from leaves. J. Biol. Chem. 281 (2006) 22684-22694
38. Matsuda M., Korn B.S., Hammer R.E., Moon Y.A., Komuro R., Horton J.D., Goldstein J.L., Brown M.S., and Shimomura I. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. 15 (2001) 1206-1216
39. McGarry J.D., Mannaerts G.P., and Foster D.W. Characteristics of fatty acid oxidation in rat liver homogenates and the inhibitory effect of malonyl-CoA. Biochim. Biophys. Acta 530 (1978) 305-313
40. Mesaros A., Koralov S.B., Rother E., Wunderlich F.T., Ernst M.B., Barsh G.S., Rajewsky K., and Bruning J.C. Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. Cell Metab. 7 (2008) 236-248
41. Moitra J., Mason M.M., Olive M., Krylov D., Gavrilova O., Marcus-Samuels B., Feigenbaum L., Lee E., Aoyama T., Eckhaus M., et al. Life without white fat: a transgenic mouse. Genes Dev. 12 (1998) 3168-3181
42. Murata Y., Robertson K.M., Jones M.E., and Simpson E.R. Effect of estrogen deficiency in the male: the ArKO mouse model. Mol. Cell. Endocrinol. 193 (2002) 7-12
43. Nagle C.A., An J., Shiota M., Torres T.P., Cline G.W., Liu Z.X., Wang S., Catlin R.L., Shulman G.I., Newgard C.B., and Coleman R.A. Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J. Biol. Chem. 282 (2007) 14807-14815
44. Seip M., and Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr. Suppl. 413 (1996) 2-28
45. Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S., and Goldstein J.L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated Srebp-1a. J. Clin. Invest. 98 (1996) 1575-1584
46. Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S., and Goldstein J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99 (1997) 846-854
47. Shimomura I., Hammer R.E., Richardson J.A., Ikemoto S., Bashmakov Y., Goldstein J.L., and Brown M.S. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12 (1998) 3182-3194
48. Shimomura I., Bashmakov Y., and Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274 (1999) 30028-30032
49. Shimomura I., Matsuda M., Hammer R.E., Bashmakov Y., Brown M.S., and Goldstein J.L. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6 (2000) 77-86
50. Sigal Y.J., McDermott M.I., and Morris A.J. Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. Biochem. J. 387 (2005) 281-293
51. Smith S.J., Cases S., Jensen D.R., Chen H.C., Sande E., Tow B., Sanan D.A., Raber J., Eckel R.H., and Farese Jr. R.V. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet. 25 (2000) 87-90
52. Stone S.J., Myers H.M., Watkins S.M., Brown B.E., Feingold K.R., Elias P.M., and Farese Jr. R.V. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 279 (2004) 11767-11776
53. Tang W., Yuan J., Chen X., Gu X., Luo K., Li J., Wan B., Wang Y., and Yu L. Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway. J. Biochem. Mol. Biol. 39 (2006) 626-635
54. Unger R.H. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol. Metab. 14 (2003) 398-403
55. Uyeda K., and Repa J.J. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab. 4 (2006) 107-110
56. Van Maldergem L., Magre J., Khallouf T.E., Gedde-Dahl Jr. T., Delepine M., Trygstad O., Seemanova E., Stephenson T., Albott C.S., Bonnici F., et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J. Med. Genet. 39 (2002) 722-733
57. Vergnes L., Beigneux A.P., Davis R., Watkins S.M., Young S.G., and Reue K. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J. Lipid Res. 47 (2006) 745-754
58. West J., Tompkins C.K., Balantac N., Nudelman E., Meengs B., White T., Bursten S., Coleman J., Kumar A., Singer J.W., and Leung D.W. Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells. DNA Cell Biol. 16 (1997) 691-701
59. Yang J., Goldstein J.L., Hammer R.E., Moon Y.A., Brown M.S., and Horton J.D. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc. Natl. Acad. Sci. USA 98 (2001) 13607-13612
60. Ye G.M., Chen C., Huang S., Han D.D., Guo J.H., Wan B., and Yu L. Cloning and characterization a novel human 1-acyl-sn-glycerol-3-phosphate acyltransferase gene AGPAT7. DNA Seq. 16 (2005) 386-390
61. Yen C.L., and Farese Jr. R.V. MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine. J. Biol. Chem. 278 (2003) 18532-18537
62. Yen C.L., Stone S.J., Cases S., Zhou P., and Farese Jr. R.V. Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase. Proc. Natl. Acad. Sci. USA 99 (2002) 8512-8517